Question 1

Cholestyramine (Novo-Cholamine)and colestipol (Colestid)are most effective in the treatment of which type of hyperlipoproteinemia?

Accepted Answer

A) Type V 
B) Mixed 
C) All types 
D) Type II 
A) Type V 
B) Mixed 
C) All types 
D) Type II D

Question 2

Patients who are receiving antilipemic drugs need to be closely monitored for the development of which adverse effect?

Accepted Answer

A) Photosensitivity 
B) Pulmonary problems 
C) Vitamin C deficiency 
D) Liver dysfunction 
A) Photosensitivity 
B) Pulmonary problems 
C) Vitamin C deficiency 
D) Liver dysfunction D

Question 3

A patient is receiving an antilipemic drug.The nurse should tell the patient to do what in regard to this medication?

Accepted Answer

A) Begin a vigorous aerobic exercise program. 
B) Eat extra servings of raw vegetables and fruit. 
C) If a once-a-day dosage regimen is used, take the medication in the morning. 
D) To maximize drug absorption, take the medication 1 hour before meals or 2 hours after meals. 
A) Begin a vigorous aerobic exercise program. 
B) Eat extra servings of raw vegetables and fruit. 
C) If a once-a-day dosage regimen is used, take the medication in the morning. 
D) To maximize drug absorption, take the medication 1 hour before meals or 2 hours after meals. B

Question 4

A patient is taking a statin drug.What important action should the nurse tell this patient to take?

Accepted Answer

A) Have a hearing assessment done. 
B) Have an ophthalmic assessment done. 
C) See a physiotherapist. 
D) Take the medication with breakfast. 
A) Have a hearing assessment done. 
B) Have an ophthalmic assessment done. 
C) See a physiotherapist. 
D) Take the medication with breakfast.

Question 5

A patient is taking gemfibrozil to lower her cholesterol level.
Which adverse effect of this medication should the nurse tell the patient about?

Accepted Answer

A) Constipation 
B) Diarrhea 
C) Joint pain 
D) Dry mouth 
A) Constipation 
B) Diarrhea 
C) Joint pain 
D) Dry mouth

Question 6

Which patient is a likely candidate for drug therapy for cholesterol reduction?

Accepted Answer

A) A female patient with a waist circumference greater than 95 cm and a triglyceride level greater than or equal to 1.7 mmol/L 
B) A male patient with a high-density lipoprotein cholesterol (HDL-
C)  level greater than 1 mmol/L and blood pressure (BP) greater than 130/85 mm Hg 
C) A female patient with an HDL-C level greater than 1.3 mmol/L and BP greater than 130/85 mm Hg 
D) A male patient with a waist circumference greater than 102 cm and a triglyceride level of 1.7 mmol/L or higher 
A) A female patient with a waist circumference greater than 95 cm and a triglyceride level greater than or equal to 1.7 mmol/L 
B) A male patient with a high-density lipoprotein cholesterol (HDL-
C)  level greater than 1 mmol/L and blood pressure (BP) greater than 130/85 mm Hg 
C) A female patient with an HDL-C level greater than 1.3 mmol/L and BP greater than 130/85 mm Hg 
D) A male patient with a waist circumference greater than 102 cm and a triglyceride level of 1.7 mmol/L or higher

Question 7

A patient is beginning antilipemic therapy with an HMG-CoA reductase inhibitor.What food should the nurse tell the patient about when discussing possible drug-food interactions?

Accepted Answer

A) Oatmeal 
B) Grapefruit juice 
C) Licorice 
D) Dairy products 
A) Oatmeal 
B) Grapefruit juice 
C) Licorice 
D) Dairy products

Question 8

What should be a patient be told to do to minimize the undesirable adverse effects of nicotinic acid?

Accepted Answer

A) Take the drug on an empty stomach. 
B) Start off with a high initial dosage. 
C) Take small doses of Aspirin with the drug. 
D) Take the drug with large amounts of fibre. 
A) Take the drug on an empty stomach. 
B) Start off with a high initial dosage. 
C) Take small doses of Aspirin with the drug. 
D) Take the drug with large amounts of fibre.

Question 9

Ezetimibe (Ezetrol),a newer antilipemic drug,works by doing what?

Accepted Answer

A) Preventing the resorption of bile acids from the small intestines 
B) Inhibiting HMG-CoA reductase 
C) Activating lipase, which breaks down cholesterol 
D) Inhibiting cholesterol absorption in the small intestine 
A) Preventing the resorption of bile acids from the small intestines 
B) Inhibiting HMG-CoA reductase 
C) Activating lipase, which breaks down cholesterol 
D) Inhibiting cholesterol absorption in the small intestine

Question 10

Which lipoproteins are indicative of a high risk for developing an atherosclerotic plaque formation?

Accepted Answer

A) Chylomicrons 
B) Low-density lipoproteins (LDLs) 
C) High-density lipoproteins (HDLs) 
D) Very-low-density lipoproteins 
A) Chylomicrons 
B) Low-density lipoproteins (LDLs) 
C) High-density lipoproteins (HDLs) 
D) Very-low-density lipoproteins

Question 11

A patient who has recently started therapy with a statin drug asks the nurse how long it will take for an effect on his serum cholesterol to be seen.Which is the nurse's best response to the patient's question?

Accepted Answer

A) "Blood levels return to normal within a week of beginning therapy." 
B) "It takes several weeks to see a change in cholesterol levels." 
C) "It takes at least 6 months to see a change in cholesterol levels." 
D) "You will need to take this medication for almost a year to see significant results." 
A) "Blood levels return to normal within a week of beginning therapy." 
B) "It takes several weeks to see a change in cholesterol levels." 
C) "It takes at least 6 months to see a change in cholesterol levels." 
D) "You will need to take this medication for almost a year to see significant results."

Question 12

The nurse should monitor for myopathy (muscle pain)when a patient is taking which class of antilipemic drugs?

Accepted Answer

A) Bile acid sequestrants 
B) Hydroxymethylglutaryl-coenzyme A (HMG-Co
A)  reductase inhibitors 
C) Fibric acid derivatives 
D) Niacin 
A) Bile acid sequestrants 
B) Hydroxymethylglutaryl-coenzyme A (HMG-Co
A)  reductase inhibitors 
C) Fibric acid derivatives 
D) Niacin

Question 13

A patient reports that the cholestyramine resin powder (Olestyr)that was started yesterday clumps and sticks to the glass when being mixed.What is the nurse's best suggestion to the patient for mixing this medication for administration?

Accepted Answer

A) Use a carbonated soft drink to dissolve the powder faster. 
B) Add the powder to any liquid and stir vigorously to dissolve it quickly. 
C) Mix the powder with food or with 120 to 180 mL of fluid. 
D) Sprinkle the powder into a spoon and take it dry, followed with a glass of water. 
A) Use a carbonated soft drink to dissolve the powder faster. 
B) Add the powder to any liquid and stir vigorously to dissolve it quickly. 
C) Mix the powder with food or with 120 to 180 mL of fluid. 
D) Sprinkle the powder into a spoon and take it dry, followed with a glass of water.

Question 14

Which are considered positive risk factors for coronary artery disease? (Select all that apply.)

Accepted Answer

A) Male aged 40 years or older 
B) Female aged 40 years or older 
C) Family history that includes a sister who died of a myocardial infarction at age 58 
D) Family history that includes a brother who died of a myocardial infarction at age 40 
E) Current cigarette smoker
F)Slight build
G)Hypertension
H)History of gallbladder disease 
A) Male aged 40 years or older 
B) Female aged 40 years or older 
C) Family history that includes a sister who died of a myocardial infarction at age 58 
D) Family history that includes a brother who died of a myocardial infarction at age 40 
E) Current cigarette smoker
F)Slight build
G)Hypertension
H)History of gallbladder disease

Exam 28: Antilipemic Drugs

Cholestyramine (Novo-Cholamine)and colestipol (Colestid)are most effective in the treatment of which type of hyperlipoproteinemia?

Patients who are receiving antilipemic drugs need to be closely monitored for the development of which adverse effect?

A patient is receiving an antilipemic drug.The nurse should tell the patient to do what in regard to this medication?

A patient is taking a statin drug.What important action should the nurse tell this patient to take?

A patient is taking gemfibrozil to lower her cholesterol level. Which adverse effect of this medication should the nurse tell the patient about?

Which patient is a likely candidate for drug therapy for cholesterol reduction?

A patient is beginning antilipemic therapy with an HMG-CoA reductase inhibitor.What food should the nurse tell the patient about when discussing possible drug-food interactions?

What should be a patient be told to do to minimize the undesirable adverse effects of nicotinic acid?

Ezetimibe (Ezetrol),a newer antilipemic drug,works by doing what?

Which lipoproteins are indicative of a high risk for developing an atherosclerotic plaque formation?

A patient who has recently started therapy with a statin drug asks the nurse how long it will take for an effect on his serum cholesterol to be seen.Which is the nurse's best response to the patient's question?

The nurse should monitor for myopathy (muscle pain)when a patient is taking which class of antilipemic drugs?

A patient reports that the cholestyramine resin powder (Olestyr)that was started yesterday clumps and sticks to the glass when being mixed.What is the nurse's best suggestion to the patient for mixing this medication for administration?

Which are considered positive risk factors for coronary artery disease? (Select all that apply.)

Nursing Practice in Canada and Drug Therapy

Pharmacological Principles

Legal and Ethical Considerations

Patient Focused Considerations

Gene Therapy and Pharmacogenomics

Medication Errors: Preventing and Responding

Patient Education and Drug Therapy

Over-the-Counter Drugs and Natural Health Products

Vitamins and Minerals

Principles of Drug Administration

Analgesic Drugs

General and Local Anaesthetics

Central Nervous System Depressants and Muscle Relaxants

Central Nervous System Stimulants and Related Drugs

Antiepileptic Drugs

Antiparkinsonian Drugs

Psychotherapeutic Drugs

Substance Misuse

Adrenergic Drugs

Adrenergic-Blocking Drugs

Cholinergic Drugs

Cholinergic-Blocking Drugs

Antihypertensive Drugs

Antianginal Drugs

Heart Failure Drugs

Antidysrhythmic Drugs

Coagulation Modifier Drugs

Diuretic Drugs

Fluids and Electrolytes

Pituitary Drugs

Thyroid and Antithyroid Drugs

Antidiabetic Drugs

Adrenal Drugs

Women’s Health Drugs

Men’s Health Drugs

Antihistamines,Decongestants,Antitussives,and Expectorants

Respiratory Drugs

Acid-Controlling Drugs

Antidiarrheal Drugs and Laxatives

Antiemetic and Anti-nausea Drugs

Nutritional Supplements

Antibiotics, Part 1: Sulfonamides, Penicillins, Cephalosporins, Macrolides, and Tetracyclines

Antibiotics Part 2: Aminoglycosides, Fluoroquinolones, and Other Drugs

Antiviral Drugs

Antitubercular Drugs

Antifungal Drugs

Antimalarial, Antiprotozoal, and Anthelmintic Drugs

Anti-Inflammatory and Antigout Drugs

Immunosuppressant Drugs

Immunizing Drugs and Pandemic Preparedness

Antineoplastic Drugs Part 1: Cancer Overview and Cell Cycle–Specific Drugs

Antineoplastic Drugs Part 2: Cell Cycle–Nonspecific and Miscellaneous Drugs

Biological Response–Modifying Drugs

Anemia Drugs

Dermatological Drugs

Ophthalmic Drugs

Otic Drugs

Filters